209 Items, 11 Pages <<Prev 1 2 3 4 5 6 7 8 9 10 Next>> All
| No. | Name of Lifestyle | Third Class | Second Class | First Class | Type | No. of Studies |
|---|---|---|---|---|---|---|
| 21 | antihypertensive | Antihypertensive | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 22 | Aspirin | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 23 | azelate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 24 | Barium enema | Ionising radiation | Accessory examination | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 25 | Barium meal | Ionising radiation | Accessory examination | Clinical characteristics | No statistical significance factor | 1 |
| 26 | Benign prostatic hyperplasia | Prostate diseases | Diseases | Clinical characteristics | Risk factor | 1 |
| 27 | Benign prostatic hypertrophy | Prostate diseases | Diseases | Clinical characteristics | Risk factor | 1 |
| 28 | Benign prostatic hypertrophy medication | Benign prostatic hypertrophy(BPH) medication | Drug | Clinical characteristics | Protective factor Risk factor No statistical significance factor | 1 |
| 29 | Blood glucose | Blood glucose | Biochemical examination | Clinical characteristics | No statistical significance factor | 1 |
| 30 | Blood glucose levels amongnon,diabetics | Blood glucose | Biochemical examination | Clinical characteristics | No statistical significance factor | 1 |
| 31 | Blood pressure | Blood pressure | Biochemical examination | Clinical characteristics | No statistical significance factor | 1 |
| 32 | Blood pressure medication | Metabolic syndrome(MetS) | Diseases | Clinical characteristics | No statistical significance factor | 1 |
| 33 | Body fat | Body fat | Biochemical examination | Clinical characteristics | Protective factor No statistical significance factor | 2 |
| 34 | Body mass index | Body mass index(BMI) | Biochemical examination | Clinical characteristics | Protective factor Risk factor No statistical significance factor | 27 |
| 35 | Body mass indexat diagnosis | Body mass index(BMI) | Biochemical examination | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 36 | Brugada-like ECG | Brugada-like ECG | Accessory examination | Clinical characteristics | Risk factor | 1 |
| 37 | C-peptide distribution | Insulin | Biochemical examination | Clinical characteristics | Protective factor No statistical significance factor | 1 |
| 38 | Cardiovascular disease | Cardiovascular disease(CVD) | Diseases | Clinical characteristics | No statistical significance factor | 1 |
| 39 | Chlamydia | Chlamydia | Diseases | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 40 | Cholesterol-lowering drugs | Cholesterol-lowering drugs | Drug | Clinical characteristics | Protective factor No statistical significance factor | 1 |